Clinical Trial Update: The COSMYC Trial (COmbined Suppression of MYC) [Phase 2]

View source ↗

Summary

The COSMYC trial (Combined Suppression of MYC) is a Phase 2 study in metastatic castration-resistant prostate cancer that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 2 | Status: RECRUITING